Nikolas Stoecklein, Professor, Experimental Surgical Oncology at University of Duesseldorf in Germany, discusses the value of liquid biopsy samples, in particular, analysis of circulating tumor cells (CTCs) which can provide additional information beyond circulating tumor DNA (ctDNA).​ Include URL: 0:00 In Conversation with Nikolas Stoekcklein - More to see with Liquid Biopsy 0:04 What makes Circulating tumor cells unique? 0:30 What is the next step in CTC research to enable CTC molecular profiling? 01:18 Can CTC analysis be utilized in drug development pipelines? 01:54 What’s your wish for the future? https://emea.illumina.com/destination/more-to-see-with-liquid-biopsy.html?media=9087818&utm_medium=paidsearch&catt=paidsearch_YouTube M EMEA 01548 #liquidbiopsy ​ #CTC​ #ctDNA​ #precisionmedicine Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM LinkedIn: https://www.linkedin.com/company/illumina X: https://x.com/illumina Instagram: https://www.instagram.com/illuminainc/ Facebook: https://www.facebook.com/illuminainc TikTok: https://www.tiktok.com/@illuminainc